Levofloxacin prophylaxis for pediatric leukemia patients: monitoring of outcomes for sustained benefit and consequences.
Antimicrob Steward Healthc Epidemiol
; 4(1): e90, 2024.
Article
in En
| MEDLINE
| ID: mdl-38807931
ABSTRACT
Levofloxacin prophylaxis reduces bloodstream infections in neutropenic patients with acute myeloid leukemia or relapsed acute lymphoblastic leukemia. A retrospective, longitudinal cohort study compares incidence of bacteremia, multidrug-resistant organisms (MDRO), and Clostridioides difficile (CDI) between time periods of levofloxacin prophylaxis implementation. Benefits were sustained without increasing MDRO or CDI.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Antimicrob Steward Healthc Epidemiol
Year:
2024
Document type:
Article
Affiliation country:
Estados Unidos
Country of publication:
Reino Unido